ICG and SLN Mapping
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SLN mapping using technetium-99m +/- isosulfan blue dye|DEVICE: SLN mapping with ICG fluorescence using the Asimov Platform
Sponsor: University of Wisconsin, Madison
Collaborators: OnLume Inc.|National Cancer Institute (NCI)